Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1046634]Researchers: E/Pr Keryn Williams (Principal investigator) , A/Pr Celia Chen , A/Pr Sonja Klebe , Dr Helen Brereton
Brief description We plan to show that an engineered antibody fragment against vascular endothelial growth factor-B is an effective therapeutic drug for two eye diseases, corneal neovascularization and age-related macular degeneration. The innovative aspects of this approach are that it may be safer, and have a different spectrum of activity, than existing ophthalmic anti-angiogenic agents. Furthermore, it may be effective for corneal disease when administered as an eye-drop.
Funding Amount $AUD 464,295.73
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1046634
- PURL : https://purl.org/au-research/grants/nhmrc/1046634
